EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 39 / No 3 (Mars 2023) Med Sci (Paris), 39 3 (2023) 253-261 References
Free Access
Issue
Med Sci (Paris)
Volume 39, Number 3, Mars 2023
Néphrologie pédiatrique : de grandes avancées et un futur rempli d’espoir
Page(s) 253 - 261
Section M/S Revues
DOI https://doi.org/10.1051/medsci/2023025
Published online 21 March 2023
  1. Levy M, Feingold J. Estimating prevalence in single-gene kidney diseases progressing to renal failure. Kidney Int 2000 ; 58 : 925–943. [CrossRef] [PubMed] [Google Scholar]
  2. Gahl WA, Thoene JG, Schneider JA. Cystinosis. N Engl J Med 2002 ; 347 : 111–121. [CrossRef] [PubMed] [Google Scholar]
  3. Gahl WA, Schneider JA, Aula P. Lysosomal transport disorders : cystinosis and sialic acid storage disorders. In: The Metabolic and Molecular Basis of Inherited Disease. eds Scriver CR, Beaudet AL, Sly WS, Valle D. 7th ed. 1995 : 3763–97. [Google Scholar]
  4. Haffner D, Weinfurth A, Manz Fet al. Long-term outcome of paediatric patients with hereditary tubular disorders. Nephron 1999 ; 83 : 250–260. [CrossRef] [PubMed] [Google Scholar]
  5. Lemire J, Kaplan BS. The various renal manifestations of the nephropathic form of cystinosis. Am J Nephrol 1984 ; 4 : 81–85. [CrossRef] [PubMed] [Google Scholar]
  6. Langman CB, Moore ES, Thoene JG, Schneider JA. Renal failure in a sibship with late-onset cystinosis. J Pediatr 1985 ; 107 : 755–756. [CrossRef] [PubMed] [Google Scholar]
  7. Lietman PS, Frazier PD, Wong VG. et al. Adult cystinosis-a benign disorder. Am J Med 1966; 40 : 511–7. [CrossRef] [PubMed] [Google Scholar]
  8. Gahl WA, Reed GF, Thoene JGet al. Cysteamine therapy for children with nephropathic cystinosis. N Engl J Med 1987 ; 316 : 971–977. [CrossRef] [PubMed] [Google Scholar]
  9. Dohil R, Fidler M, Gangoiti JAet al. Twice-daily cysteamine bitartrate therapy for children with cystinosis. J Pediatr 2010 ; 156: 71–5 e1–3. [CrossRef] [PubMed] [Google Scholar]
  10. Schneider JA. Approval of cysteamine for patients with cystinosis. Pediatr Nephrol 1995 ; 9 : 254. [CrossRef] [PubMed] [Google Scholar]
  11. The Cystinosis Collaborative Research Group. Linkage of the gene for cystinosis to markers on the short arm of chromosome 17. Nat Genet 1995 ; 10 : 246–248. [CrossRef] [PubMed] [Google Scholar]
  12. Town M, Jean G, Cherqui Set al. A novel gene encoding an integral membrane protein is mutated in nephropathic cystinosis. Nat Genet 1998 ; 18 : 319–324. [CrossRef] [PubMed] [Google Scholar]
  13. Cherqui S, Kalatzis V, Trugnan G, Antignac C. The targeting of cystinosin to the lysosomal membrane requires a tyrosine-based signal and a novel sorting motif. J Biol Chem 2001 ; 276 : 13314–13321. [CrossRef] [PubMed] [Google Scholar]
  14. Kalatzis V, Cherqui S, Antignac C, Gasnier B. Cystinosin, the protein defective in cystinosis, is a H(+)-driven lysosomal cystine transporter. Embo J 2001 ; 20 : 5940–5949. [CrossRef] [PubMed] [Google Scholar]
  15. Zhai Y, Heijne WH, Smith DW, Saier MH, Jr.. Homologues of archaeal rhodopsins in plants, animals and fungi : structural and functional predications for a putative fungal chaperone protein. Biochim Biophys Acta 2001 ; 1511 : 206–223. [CrossRef] [PubMed] [Google Scholar]
  16. Kalatzis V, Nevo N, Cherqui Set al. Molecular pathogenesis of cystinosis : effect of CTNS mutations on the transport activity and subcellular localization of cystinosin. Hum Mol Genet 2004 ; 13 : 1361–1371. [CrossRef] [PubMed] [Google Scholar]
  17. Gaide Chevronnay HP, Janssens V, Van Der Smissen P, et al., A mouse model suggests two mechanisms for thyroid alterations in infantile cystinosis: decreased thyroglobulin synthesis due to endoplasmic reticulum stress/unfolded protein response and impaired lysosomal processing. Endocrinology 2015 ; 156 : 2349–2364. [CrossRef] [PubMed] [Google Scholar]
  18. Forestier L, Jean G, Attard Met al. Molecular characterization of CTNS deletions in nephropathic cystinosis : development of a PCR-based detection assay. Am J Hum Genet 1999 ; 65 : 353–359. [CrossRef] [PubMed] [Google Scholar]
  19. Cherqui S, Kalatzis V, Forestier L, et al. Identification and characterisation of the murine homologue of the gene responsible for cystinosis. Ctns. BMC Genomics 2000 ; 1 : 2. [CrossRef] [Google Scholar]
  20. Dufier JL, Dhermy P, Gubler MC, et al. Ocular changes in long-term evolution of infantile cystinosis. Ophthalmic Paediatr Genet 1987 ; 8 : 131–137. [CrossRef] [PubMed] [Google Scholar]
  21. Nevo N, Chol M, Bailleux A, et al. Renal phenotype of the cystinosis mouse model is dependent upon genetic background. Nephrol Dial Transplant 2010 ; 25 : 1059–1066. [CrossRef] [PubMed] [Google Scholar]
  22. Syres K, Harrison F, Tadlock M, et al. Successful treatment of the murine model of cystinosis using bone marrow cell transplantation. Blood 2009 ; 114 : 2542–2552. [CrossRef] [PubMed] [Google Scholar]
  23. Yeagy BA, Harrison F, Gubler MC, et al. Kidney preservation by bone marrow cell transplantation in hereditary nephropathy. Kidney Int 2011 ; 79 : 1198–1206. [CrossRef] [PubMed] [Google Scholar]
  24. Goodman S, Naphade S, Khan M, et al. Macrophage polarization impacts tunneling nanotube formation and intercellular organelle trafficking. Sci Rep 2019 ; 9 : 14529. [CrossRef] [PubMed] [Google Scholar]
  25. Naphade S, Sharma J, Gaide Chevronnay HP, et al. Brief reports : lysosomal cross-correction by hematopoietic stem cell-derived macrophages via tunneling nanotubes. Stem Cells 2015 ; 33 : 301–309. [CrossRef] [PubMed] [Google Scholar]
  26. Gaide Chevronnay HP, Janssens V, Van Der Smissen P, et al. Hematopoietic Stem Cells Transplantation Can Normalize Thyroid Function in a Cystinosis Mouse Model. Endocrinology 2016 ; 157 : 1363–1371. [CrossRef] [PubMed] [Google Scholar]
  27. Rocca CJ, Kreymerman A, Ur SN, et al. Treatment of Inherited Eye Defects by Systemic Hematopoietic Stem Cell Transplantation. Invest Ophthalmol Vis Sci 2015 ; 56 : 7214–7223. [CrossRef] [PubMed] [Google Scholar]
  28. Haschemi A, Kosma P, Gille L, et al. The sedoheptulose kinase CARKL directs macrophage polarization through control of glucose metabolism. Cell Metab 2012 ; 15 : 813–826. [CrossRef] [PubMed] [Google Scholar]
  29. Goodman S, Khan M, Sharma J, et al. Deficiency of the sedoheptulose kinase (Shpk) does not alter the ability of hematopoietic stem cells to rescue cystinosis in the mouse model. Mol Genet Metab 2021; 134 : 309–16. [CrossRef] [PubMed] [Google Scholar]
  30. Elmonem MA, Veys K, Oliveira Arcolino F, et al. Allogeneic HSCT transfers wild-type cystinosin to nonhematological epithelial cells in cystinosis : First human report. Am J Transplant 2018 ; 18 : 2823–2828. [CrossRef] [PubMed] [Google Scholar]
  31. Cartier N, Hacein-Bey-Abina S, Bartholomae CC, et al. Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy. Science 2009 ; 326 : 818–823. [Google Scholar]
  32. Harrison F, Yeagy BA, Rocca CJ, et al. Hematopoietic stem cell gene therapy for the multisystemic lysosomal storage disorder cystinosis. Mol Ther 2013 ; 21 : 433–444. [CrossRef] [PubMed] [Google Scholar]
  33. Yannaki E, Karponi G, Zervou F, et al. Hematopoietic stem cell mobilization for gene therapy : superior mobilization by the combination of granulocyte-colony stimulating factor plus plerixafor in patients with beta-thalassemia major. Hum Gene Ther 2013 ; 24 : 852–860. [CrossRef] [PubMed] [Google Scholar]
  34. Cherqui S, Sevin C, Hamard G, et al. Intralysosomal cystine accumulation in mice lacking cystinosin, the protein defective in cystinosis. Mol Cell Biol 2002 ; 22 : 7622–7632. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.